Advertisement
Advertisement

BWAY

BWAY logo

Brainsway Ltd. - ADR

13.73
USD
Sponsored
-0.13
-0.94%
Mar 26, 14:28 UTC -4
Open

BWAY Earnings Reports

Positive Surprise Ratio

BWAY beat 12 of 17 last estimates.

71%

Next Report

Date of Next Report
May 11, 2026
Estimate for Q1 26 (Revenue/ EPS)
$49.14M
/
$0.17
Implied change from Q4 25 (Revenue/ EPS)
+4.13%
/
-34.62%
Implied change from Q1 25 (Revenue/ EPS)
+18.09%
/
+142.86%

Brainsway Ltd. - ADR earnings per share and revenue

On Mar 11, 2026, BWAY reported earnings of 0.26 USD per share (EPS) for Q4 25, beating the estimate of 0.13 USD, resulting in a 98.02% surprise. Revenue reached 47.19 million, compared to an expected 46.13 million, with a 2.30% difference. The market reacted with a +8.34% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 3 analysts forecast an EPS of 0.17 USD, with revenue projected to reach 49.14 million USD, implying an decrease of -34.62% EPS, and increase of 4.13% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Capricor Therapeutics Inc
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.55
Actual
-$0.62
Surprise
-12.56%
logo
Kestra Medical Technologies, Ltd. Common Stock
Report Date
Mar 17, 2026 For Q3 26
Estimate
-$0.60
Actual
-$0.61
Surprise
-0.39%
logo
Sundial Growers Inc. Common Shares
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.01
Actual
$0.04
Surprise
+499.62%
logo
High Tide Inc. Common Shares
Report Date
Mar 17, 2026 For Q1 26
Estimate
$0.00
Actual
$0.01
Surprise
+447.68%
logo
Sanara MedTech Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
$0.11
Actual
$0.04
Surprise
-64.35%
logo
Cytosorbents Corp.
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.09
Surprise
-76.47%
logo
Nephros Inc.
Report Date
Mar 12, 2026 For Q4 25
Estimate
$0.01
Actual
$0.08
Surprise
+684.31%
FAQ
For Q4 2025, Brainsway Ltd. - ADR reported EPS of $0.26, beating estimates by 98.02%, and revenue of $47.19M, 2.3% above expectations.
The stock price moved up 8.34%, changed from $12.71 before the earnings release to $13.77 the day after.
The next earning report is scheduled for May 11, 2026.
Based on 3 analysts, Brainsway Ltd. - ADR is expected to report EPS of $0.17 and revenue of $49.14M for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement